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SECTION II
HISTORICAL REVIEW
HISTORICAL REVIEW
Density-dependent Cell Growth
Cell-cell interactions are involved in the
regulation of cell growth. The study of such cellular
interactions and cell growth control was simplified by
the development of in vitro cultivation. Eukaryotic
cells were first successfully grown in culture in the
early 1900s by Harrison (1907) and Carrel (1912), and
these earliest studies of cultured cells included simple
observations of cellular behavior in this unnatural
environment. Abercrombie and Heaysman (1954) described
the formation of "monolayers" of cells grown in hanging
drop slides and demonstrated that the cellular
arrangement into monolayers resulted from "contact
inhibition." Contact inhibition referred to the
phenomenon whereby cellular movement was restricted
through cell-cell contact. Since that initial
observation, numerous researchers have explored the
causes of such cell behavior.
Further investigations suggested that not only was
cell motility diminished, but also cell proliferation was
reduced upon cell-cell contact. Later, these two events
were seen to be separate; Stoker and Rubin (1967)
proposed terminology to distinguish between contact
inhibition, meaning restricted movement of cells, and
density-dependent inhibition, meaning restricted growth
of cells. Subsequently, however, these terms have been
used inter-changeably in reference to cell growth
control
.
A loss of contact or density-dependent inhibition of
cell growth was correlated to tumor igenicity of cell
populations. Aaronson and Todaro (1968) found that cell
lines which grew efficiently at high saturation densities
in vitro produced tumors in vivo more frequently than
cell lines which demonstrated contact inhibition in
culture. About the same time, Holley and Kiernan (1968)
demonstrated that contact inhibition of cells in culture
could be overcome by serum factors. They found that the
final cell density was directly proportional to the
concentration of serum in the medium. In other words,
the more serum (thus, serum factors) present, the greater
the number of cells produced in a given time and space.
Such growth-promoting molecules have been the object of
many investigative pursuits.
Positive Growth Regulators
Enhancement of cellular proliferation has been
attributed to many agents including known transforming
substances (such as viruses and phorbol esters), serum
factors and cell-associated molecules. The numerous
transforming substances are beyond the scope of this
review and the serum components have not yet been
completely identified; therefore, only those agents
isolated from cells will be discussed here.
The majority of cell-derived molecules have been
described as polypeptide growth factors. These
polypeptide growth factors are similar to hormones in
that they are relatively small polypeptides and that they
are released and received by cells. Several such
molecules have been isolated, purified and characterized
in detail; while others have been purified and/or
characterized to a lesser extent.
One of the first of these molecules to be isolated
and carefully studied was epidermal growth factor (EGF).
EGF activity was initially discovered about thirty years
ago in an extract of mouse submaxillary glands by Cohen
(1962), while he was studying nerve growth factor (NGF).
Later, Cohen also isolated EGF from human urine (Cohen
and Carpenter, 1975), where originally it was described
as urogastrone and subsequently determined to be
equivalent to EGF . The physical properties of EGF
include a low molecular weight of approximately 6,000
Daltons and an isoelectric point of 4.6. Its amino acid
sequence has been determined, revealing a single
polypeptide chain of 53 residues with three
intramolecular disulfide bonds (Taylor et al., 1972).
Generally, EGF elicits a mitogenic response in cultured
cells, and the response has been characterized
experimentally by increased cell density and increased
macromolecular synthesis, including DNA, RNA and protein
(Cohen and Stastny, 1968; Hoober and Cohen, 1967a; 1967b;
Westermark, 1976). Additionally, biological responses to
EGF, which have been measured in various cells, involve
ion transport, glycolysis, membrane alterations, viral
growth and production of specific molecules (i.e. human
chorionic gonadotropin, prostaglandin, etc.) (Carpenter
and Cohen, 1979)
.
NGF activity was described by Bueker in 1948 in a
mouse sarcoma. NGF was subsequently discovered in mouse
submaxillary gland, snake venom, chick embryo, rat
granuloma and other tissues and cells (reviewed in
Gospodarowicz and Moran, 1976). The purified polypeptide
was determined to be a dimer consisting of chains of 118
amino acids bonded by three disulfide linkages (Angeletti
and Bradshaw, 1971). Structurally and functionally, NGF
is similar to both insulin and EGF , although it does not
exhibit a mitogenic effect on cultured cells. NGF must
be present in order to stabilize embryonic nerve cells in
vitro, without NGF most nerve cells would disintegrate in
culture (Bradshaw, 1978). Levi-Montalcini and Booker
(1960a) demonstrated that NGF was necessary for cultured
neurons to extend neurites. They also showed that the
sympathetic nervous system of neonatal animals injected
with anti-NGF antibodies was destroyed (1960b).
Another growth factor, which proved to be extremely
interesting, was isolated from virally-transf ormed cells
in culture and was, therefore, called transforming growth
factor-g (TGF-B). TGF-£ was shown to be a polypeptide of
25,000 Dalton molecular weight composed of two 12,500
Dalton subunits linked by disulfide bonds. TGF-ft,
although larger than EGF, was categorized with EGF due to
similarites in structure (James and Bradshaw, 1984).
TGF-0 elicited opposing biological responses from various
cells in vitro. Generally, fibroblasts were stimulated
mitogenically , while epithelial cell lines appeared to be
inhibited in proliferation. This contradictory activity
has not been fully explained through experimentation to
date, but the resolution of this paradox may uncover some
important information related to the positive and/or
negative regulation of cell growth.
These various growth factors have been proposed to
exert their influence by one of three modes of
transmission (James and Bradshaw, 1984). The first model
was related to normal hormone activity, or endocrine
secretion. Endocrine secretion described the process
whereby a molecule was produced by a cell or tissue,
released into a transport system (i.e. the bloodstream),
and subsequently, received by another cell far-removed
from the original secreting cell. Alternatively, the
released molecule might not have traversed such
distances, but merely migrated to a neighboring, non-
secreting cell where it was received. Factors confined
to a limited area illustrated the paracrine secretion
model. Independent of the reaction of distant or
neighboring cells, an actively secreting cell could
contain receptors for the released molecules, thereby
causing an effect in the manufacturing cell itself. This
process has been referred to as autocrine secretion.
Most of the growth factors have been demonstrated to
operate in a paracrine fashion, but some that utilized
endocrine (insulin-like growth factors) or autocrine
(TGFs) signaling have also been identified.
Regardless of the route of transport, these positive
growth regulators induce mitogenesis by binding to
specific receptors on the cell surface. The growth
factors do not necessarily need to be internalized into
the cell in order to initiate a response. Once a
receptor-ligand complex is formed, a cascade of events
proceeds within the cell. Among the intracellular
changes that occur following receptor binding are influx
of sodium ions, efflux of hydrogen ions, release of
stored calcium ions, increased turnover of phosphatidyl
inositols, and activation of protein kinase C (Deuel,
1987).
The multitude of changes that occur within the cell
prior to division seem to be intricately connected. For
example, the hydrolysis of phosphatidyl inositols
produces d iacylglycerol and inositol phosphates.
Inositol triphosphate may be a second messenger which
couples membrane receptor binding to the release of
intracellular calcium. At the same time, diacylglycerol
triggers the activation of protein kinase C.
Molecules which may induce the hydrolysis of
phosphitidyl inositols by acitivating phospholipase C are
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what are termed G proteins. G proteins are membrane
molecules composed of three polypeptide subunits which
dissociate upon activation. The a-subunit of G proteins
binds GTP, and in this state, is active. The active
subunit of various G proteins not only may activate
phosopholipase C, but also may stimulate or inhibit
adenylate cyclase, which alters cellular cyclic AMP
levels. Cyclic AMP triggers intracellular responses to
hormones and possibly other regulatory factors.
The various positive growth regulators cause cell
division via different pathways. Because the processes
involved in mitosis are intertwined, it is plausible that
a single inhibitory element could block the action of
more than one stimulatory factor.
11
Negative Growth Regulators
I. Soluble Factors Responsible for Inhibition
The discovery of growth stimulatory factors in serum
and various tissues, and the demonstration that cells in
culture were density-dependent growth-arrested led some
investigators to believe that antagonistic, inhibitory
factors might also exist. Some researchers believed that
such inhibitory factors might be released from cells in
response to cell-cell contact and be present in
conditioned culture media.
In 1974, the first cell-elaborated inhibitory factor
was isolated by Lipkin and Knecht (1974). This
diffusible factor which was isolated from culture media
of a contact-inhibited, amelanotic melanoma cell line was
capable of restoring contact inhibition to highly
malignant melanocytes in vitro. The factor was
demonstrated to contain protein and be of high molecular
weight, but was not purified to homogeneity. Similarly,
Holley et al. (1978) have shown that the density-
dependent regulation of growth of BSC-1 cells (African
green monkey kidney) resulted, in part, from the
accumulation of inhibitors in the medium. In 1980,
Holley et al. (1980) partially purified two high
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molecular weight growth inhibitors from culture medium of
BSC-1 cells. These factors were shown to inhibit
thymidine incorporation in BSC-1 cells by 85%. The
actual number of cells in culture was also limited by the
inhibitory proteins. The action of these inhibitors
could be counteracted by the addition of EGF . One of the
BSC-1 cell inhibitors was later shown to be structurally
similar to TGF-B (Tucker et al., 1984). In the last
decade, several other groups have isolated and/or
partially purified inhibitors from various sources. The
hepatic proliferation inhibitor (HPI) was separated from
a growth stimulatory fraction of rat liver homogenates by
McMahon, Farrelly, and Iype (1982). HPI was found to
have a molecular weight of 26,000 Daltons and an
isoelectric point of 4.65; its inhibitory activity was
demonstrated by significantly reducing the number of
colonies formed by Fischer nonmalignant rat liver cells.
Harel, Blat, and Chatelain (1985) isolated both
inhibitory and stimulatory factors from 3T3 cell
conditioned medium. The separated factors were IDF45, a
45,000 Dalton inhibitory polypeptide, and SDF10, a 10,000
Dalton stimulatory protein. IDF45 was demonstrated to
inhibit the stimulation, by SDF10, of nucleic acid
synthesis in 3T3 cells. Also from 3T3 cell conditioned
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medium, Steck et al. (1982) isolated a polypeptide
enriched fraction which they dubbed FGR-s (Fibroblast
Growth Regulator-secreted). Partially purified, FGR-s
contained two major polypeptides of molecular weights of
10,000 and 13,000 Daltons. This extract was shown to
reduce the number of 3T3 cells per colony by two-thirds.
Later, Hsu, Barry, and Wang (1984) produced a monoclonal
antibody to FGR-s that bound the 13,000 Dalton protein
and successfully neutralized the inhibitory activity.
In 1984, Boehmer et al. (1984) isolated and
subsequently purified MDGI (Mammary Derived Growth
Inhibitor) from normal bovine mammary glands. This
protein had a molecular weight of 13,000 Daltons and
inhibited the number of Ehrlich ascites mammary carcinoma
cells in vitro by up to 40%. The MDGI inhibitory effect
was not only abolished in culture by both EGF and
insulin, but also neutralized by anti-inhibitor antiserum
raised in mice. Interestingly, in 1987, Boehmer et al.
(1987) discovered that antibodies prepared against MDGI
cross-reacted with FGR-s (13 kD ) . There may be
additional revelations such as that of the MDGI and FGR-s
investigators. Such released inhibitors may function in
an autocrine, paracrine and/or endocrine fashion, and
presumably, these molecules usually act in an autocrine
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or paracrine manner. As discussed above, a number of the
inhibitors exert their effects on cells identical to
those from which they were isolated. Logically,
autocrine or paracrine secretion would explain density-
dependent behavior of cells in culture, because cells
within a confined space seem to signal themselves and/or
each other to cease proliferation. Additionally,
although positive growth regulators (growth stimulatory
factors) have been shown to be present in serum, none of
the inhibitors mentioned here have been isolated from
serum
.
II. Cell-associated Factors Responsible for Inhibition
Dulbecco and Stoker (1970) proposed that the cell
growth inhibition of normal cells in vitro might be a
result of cell-to-cell contact either directly or
indirectly. As cell membranes approach one another, the
receptors for various growth factors could be blocked,
thus indirectly stopping cell proliferation. Later,
Dulbecco (1970) showed that most likely " topoinhibition"
was not caused by occlusion of receptors, but resulted
directly from cellular interactions.
When Dulbecco showed that cell growth inhibition
seemed to be a result of direct contact, other groups
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(Burger, 1970; Sefton and Rubin, 1970) demonstrated that
cells in culture lost contact inhibition when treated
with proteolytic enzymes. Shortly thereafter, Pardee
(1971) noted that during the process of cell division,
the cell surface changed. Taken together, these
observations suggested that some cell surface protein(s)
which was(were) responsible for conferring density-
dependent inhibition of growth to cells might indeed
exist
.
Following this lead, several groups attempted to
isolate such a molecule. In 1976, Fisher and Koch (1976)
isolated inhibitory peptides by treating HeLa cells with
dilute pronase. HeLa cell surface peptides (HSP) were
shown to inhibit protein synthesis of HeLa cells in
culture and also in cell-free translation systems. HSP
were incorporated into HeLa cells rapidly and appeared to
associate with monosomes and polysomes. Using a similar
method, Yaoi (1934) isolated inhibitory glycopeptides
from primary chick embryo fibroblasts. These molecules
reduced cell growth rate and thymidine uptake of chick
embryo fibroblasts in vitro, but this inhibitory effect
was partially destroyed by neuraminidase treatment and
completely destroyed by periodate oxidation of the
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sialoglycopeptides , suggesting that carbohydrates were
responsible for the inhibition.
Finally, the Johnson laboratory isolated and
purified glycopeptides from both mouse and bovine brain
(see table for comparisons). The first glycopeptide
inhibitors were proteolytically removed from mouse
cerebral cortex cells in 1979 (Kinders, Johnson, and
Rachmeler, 1979). These molecules, called BCSG (brain
cell surface glycopeptides), had molecular weights of
10,000-25,000 Daltons and were shown to inhibit protein
synthesis of various cells in culture. Subsequently,
Kinders and Johnson (1982) isolated similar glycopeptides
from bovine cerebral cortices. The first bovine
derivative, which bound to Ulex europaeus agglutinin,
thereby suggesting the presence of fucose, had an
apparent molecular weight of 18,000 Daltons. The
glycopeptide was demonstrated to inhibit cell
proliferation and protein synthesis of BHK-21 (baby
hamster kidney) cells in vitro. More recently, another
bovine cerebral cortex glycopeptide has been purified
(Sharifi et al., 1986) which also had a molecular weight
of approximately 18,000 Daltons, but bound to Limulus
polyphemus agglutinin and not to Ulex europaeus
agglutinin, suggesting the presence of sialic acid
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instead of fucose . The sialoglycopeptide (SGP) inhibitor
reduced macromolecular synthesis and cellular mitosis in
a wide spectrum of cell types (Fattaey, Johnson, and
Chou, submitted). Binding of the SGP to a specific
receptor (Bascom, Sharifi, and Johnson, 1986) was
sufficient to produce the effects (Sharifi, Bascom, and
Johnson, 1986), which were determined to be reversible.
The inhibitor was capable of antagonizing the stimulatory
effects of bombesin (Sharifi, unpublished), TPA (12-0-
tetradecanoylphorbol-13-acetate) (Chou et al., 1987), and
EGF (Bascom, Sharifi, and Johnson, 1987).
If these molecules were indeed cell surface
proteins, then the groups highlighted above only isolated
a portion of the inhibitory proteins by limited
proteolysis. Concurrently, other investigators were
working with cell membranes. Natraj and Datta (1978)
extracted FGFR (Fibroblast Growth Regulatory Factor) from
3T3 cell membranes with urea. Previously, Whittenberger
and Glaser (1977) had demonstrated that isolated 3T3 cell
membranes were capable of inhibiting growth of cells in
culture. Also in 1978, Whittenberger et al. (1978)
proceeded to extract the inhibitory molecule from
membrane fractions with the detergent, octylglucoside
.
Proteins were then partially purified from this
18
octylglucoside extract by Raben, Lieberman, and Glaser
(1981).
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TABLE. The information illustrated was collated from the
Johnson laboratory. In each case, the cerebral cortices
were prepared similarly for isolation of the various
inhibitors. Briefly, cerebral cortex cells were treated
with dilute protease, the elaborated proteins were
ethanol precipitated and then extracted with chloroform-
methanol
.
Abbreviations are as follows: UEA-l=Ulex europaeus
agglutinin, WGA=Wheat germ agglutinin, S-E HPLC=size-
exclusion HPLC (high performance liquid chromatography),
HI HPLC=hydrophobic interaction HPLC, HA HPLC= hydroxy-
apatite HPLC, LPA = Ljjiiu1us polyphenols agglutinin, ND=not
determined, Met^methionine , Thy=thymidine , and
Urd=uridine. Molecular weights in parentheses were
determined using BioGel, others were determined by
electrophoresis.
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Comparison of inhibitors fron cerebral cortices.
Factor Murine^ Boyjjie 2
_ [I^—Bayine?
Purification Steps BiogelP-100 1 BioGelP-100 2 DEAE agarose 3
UEA-li UEA-12
CM agarose 7
Molecular Weight
Isoelectric Point
Inhibition.
:
Met incorporation
Thy incorporation
Urd incorporation
Cell division
Cell cycle block
Cell Specificity
(26,000)i
(10,000)1
ND
+ 1
ND
-4
G2S
A
(45,000)2
(10,000)2
18,0002
8.ie
WGA 3
S-E HPLC 3
HI HPLC 3
HA HPLCS
LPA3
18,0003
3.03
+ 2 + 3
ND + io
ND + 11
+ 2 +10, 12
ND G112
E c
A Primary cell lines most sensitive, transformed cell
lines least sensitive, tumor cells sensitized by ganglio-
sides . i
-
6
B Established cell lines and cells treated with
gangliosides sensitive, transformed cells insensitive
.
2
.
7
c All cells tested to date sensitive, including primary,
established, transformed, avian, and insect cell lines. 12
Kinders, Johnson, and Rachmeler, 1979.
Kinders and Johnson, 1982.
et al
.
, 1986.
et al
.
, 1980.
and Johnson, 1981.
Rintoul, and Johnson,
Shar if
i
Kinders
Kinders
Kinders, K c
Bascom et al
.
, 1985
.
Johnson, Kinders, and Sharifi, 1985.
Bascom et al
.
, 1986
i° Chou et al. , 1986.
11 Bascom et al
.
, in preparation.
12 Fattaey, Johnson, and Chou, submitted
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SECTION IV
MANUSCRIPT: IN SEARCH OF--A MEMBRANE SIALOGLYCOPROTEIN
CELL GROWTH INHIBITOR
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INTRODUCTION
The regulation of cell growth has been the subject
of many studies and several investigators have isolated
molecules from cells which inhibit cellular metabolism.
A few of these inhibitory factors have been demonstrated
to be membrane components, but none have been completely
purified as membrane proteins. The possible residence of
such molecules on the cell surface suggests that they may
play an important role in cell-cell recognition, cell-
cell communication and thus, the density-dependent growth
behavior of cells in culture. The function of such
growth inhibitors has been studied in vitro, using
purified or partially purified molecules.
Sharifi et al. (1986) have isolated and purified, to
near homogeneity, a glycopeptide inhibitor from intact
bovine cerebral cortex cells that had an apparent
molecular weight of 18,000 Daltons, an isoelectric point
of 3.0 and has been shown to contain sialic acid by
selectively binding to a Limulus polyphemus lectin
affinity column.
The sialoglycopeptide (SGP) was purified by
treating bovine cerebral cortex cells in suspension with
dilute pronase, followed by ethanol precipitation,
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chloroform/methanol extraction, DEAE-agarose
chromatography, wheat germ agglutinin chromatography,
size exclusion HPLC, and hydroxyapatite HPLC (Sharifi et
al., 1986).
The SGP inhibited the incorporation of radiolabeled
methionine into cellular proteins and radiolabeled
thymidine and uridine into cellular nucleic acids
(Sharifi et al., 1986; Bascom et al., in preparation;
Fattaey, Johnson, and Chou, submitted). The lack of
incorporation of such precursors into cellular products
suggested an inhibition of cell division. It has also
been shown that the SGP reduced the proliferation of
cells, as determined by direct cell count (Chou et al.,
1987; Fattaey, Johnson, and Chou, submitted). The
inhibitor appeared to synchronize 3T3 cells in the Gl
phase of the cell cycle and upon removal of the SGP, the
cells resumed proliferation.
In order to supress cell proliferation, the SGP did
not need to be internalized by the cells. Binding to a
specific cell surface receptor was sufficient for the SGP
to mediate its inhibition (Bascom, Sharifi, and Johnson,
1986; Sharifi, Bascom, and Johnson, 1986). Additionally,
the inhibitor was shown to be a potent antagonist of the
mitogenic activity of growth factors and a tumor
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promoter. The SGP successfully inhibited the stimulation
of cells by bombesin (Sharifi, unpublished), epidermal
growth factor (Bascom, Sharifi, and Johnson, 1987), and
TPA ( 12-(3-tetradecanoylphorbol-13-acetate) (Chou et al. ,
1987).
As stated previously, the SGP was isolated by
proteolytic cleavage from the surface of bovine cerebral
cortex cells, thereby presumably generating a fragment of
a resident membrane glycoprotein, or "parental"
glycoprotein. The inhibitory fragment was soluble in
water and therefore, unlike the typical hydrophobic
proteins found in membranes, was convenient to purify by
routine biochemical procedures that employ aqueous
solvents
.
Prior to this study, rabbit polyclonal anti-SGP
antibody was produced and the availability of this
antibody provided an opportunity to assess a "one-step"
purification scheme. Theoretically, the cell growth
inhibitor (SGP) and/or its "parental" membrane protein
could be isolated by applying an extract from cerebral
cortex cells to a matrix coupled with anti-SGP polyclonal
antibody. Such a strategy was employed in the following
attempt to purify the "parental" sialoglycoprotein in its
native state, as a membrane molecule.
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MATERIALS AND METHODS
Isolation
Slices of bovine cerebral cortex tissue were removed
from fresh bovine brain, placed in ice-cold DMEM
(Dulbecco's Modified Eagle Medium, GIBCO Laboratories
Life Technologies, Inc., Grand Island, NY) containing
25 mM HEPES buffer (pH 7.1) and weighed. A cell suspen-
sion was prepared by repeated pipetting. The cells were
pelleted by centr ifugation at 3,000 rpm for 5 minutes and
resuspended in 1-2 ml ice-cold solubilization buffer per
gram of wet tissue. Solubilization buffer contained 1%
w/v octyl-0-D-glucopyranoside (Behring Diagnostics, La
Jolla, CA), 10 nM phenylmethylsulfonylf luor ide (Serva
Fine Biochemicals , Inc., Westbury, NY), 5 nM
phosphoramidon (Sigma Chemical Company, St. Louis, MO),
10 nM leupeptin (Serva Fine Biochemicals, Inc., Westbury,
NY), 10 nM pepstatin A (Sigma Chemical Company, St.
Louis, MO), in phosphate buffered saline (PBS), where PBS
was composed of 0.9% w/v sodium chloride, 10 mM sodium
phosphate, pH 7.2. After incubation on ice for 30
minutes with periodic mixing, the suspension was
centrifuged at 5,000 rpm for 5 minutes. The supernatant
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fluid was collected and re-centrifuged at 100,000 x g for
one hour. The supernatant liquid was then concentrated
to a final volume of 10 ml by ultrafiltration using a
Diaflo YM100 membrane (Amicon Corporation, Danvers, MA).
Protein Determination
Protein content was determined by the BCA
(bicinchoninic acid) protein assay (Pierce Chemical
Company, Rockland, IL) using bovine serum albumin in PBS
containing 1% (w/v) octyl-g-D-glucopyranoside
(octylglucoside) as a standard.
Polyclonal Antibody Affinity Column
Typically, 1.5-2 ml activated agarose slurry, Affi-
gel 10 (BioRad Laboratories, Richmond, CA), were washed
with at least 5 column volumes of ice-cold distilled
water followed by approximately 5 column volumes of PBS.
Approximately 200 ug of polyclonal antibody, adjusted to
a final volume of 1 ml, were added to the column matrix
and rotated on a Fisher Hematology/Chemistry Mixer
(Fisher Scientific, Pittsburgh, PA) continuously, over-
night, at 4°C. The Affi-gel 10 was then washed with at
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least 10 column volumes of PBS and fractions were saved
to determine the amount of uncoupled antibody. Unreacted
Affi-gel 10 was then blocked by washing successively with
several volumes of 3 M ammonium thiocyanate, 50 mM
ethanolamine (pH 11.0) and/or 2 M glycine (pH 2.5).
Excess blocking agents were then removed by extensive
washing with 100-500 column volumes of PBS, followed by
equilibration with 10 column volumes of PBS containing 1%
(w/v) octylglucoside
.
Polyclonal Antibody Affinity Chromatography
Concentrated, solubilized bovine cerebral cortex
proteins were applied to the polyclonal antibody affinity
column and incubated at 4°C, overnight. The column was
washed with PBS containing 1% (w/v) octylglucoside until
no absorbance at 280 nm was detectable. Elution buffer
(1% w/v octylglucoside in either 50 mM ethanolamine or 2
M glycine) was added to elute antibody-bound proteins.
Samples were collected until absorbance was zero. A
single protein peak was eluted and the collected
fractions were pooled, dialyzed against dilute PBS
containing 1% (w/v) octylglucoside, dried in a Speed Vac
35
Concentrator (Savant Instruments, Inc., Hicksville, NY)
and stored at -20°C.
SDS-PAGE
Proteins were diluted 1:2 (v/v) in sample buffer (36
mM sodium phosphate, pH 7.2 with 35% glycerol, 4% sodium
dodecyl sulfate, 0.1% bromphenol blue with or without 18%
P-mercaptoethanol) . Samples were incubated at 100°C on a
heating block for 5-10 minutes and then were electro-
phoresed in a 5%-20% polyacrylamide gradient, essentially
by the method of Laemmli (1970). Molecular weight
standards (prestained, Bethesda Research Laboratories
Life Technologies, Inc., Gaithersburg, MD ) were myosin H-
chain (200,000), phosphorylase B (97,400), bovine serum
albumin (68,000), ovalbumin (43,000), a-chymotrypsinogen
(25,700), e-lactoglobulin (18,400) and lysozyme (14,300).
Isoelectric Focusing
Isoelectric focusing was performed by a technique
similar to the method of Vesterberg (1972). The gel was
poured between a Gel-Bond (FMC Corporation, Rockland, ME)
and glass plate sandwich, using the following solution:
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5% (v/v) acrylamide stock, 10% (v/v) glycerol, 0.9% (v/v)
Triton-X 100 (CalBiochem, La Jolla, CA), 0.3% (v/v)
Ampholine pH 4-6 (LKB Wallac, Finland), 0.3% (v/v)
Ampholine pH 5-7, 0.6% (v/v) Ampholine 9-11, 4.6% (v/v)
Ampholine pH 3.5-10, and 0.05% (w/v) ammonium persulfate.
The electrodes were saturated with 0.5 N sodium hydroxide
and 0.5 N acetic acid. After focusing for 90 minutes at
25 Watts, the gel was removed. The pH gradient was
measured using a flat-bed electrode, unless isoelectric
focusing standards were used. Broad Range IEF Standards
from BioRad included phycocyanin-pl 4.65, R-lactoglobulin
B-pI 5.10, bovine carbonic anhydrase-pl 6.00, human
carbonic anhydrase-pl 6.50, equine myoglobin-pl 7.00,
whale myoglobin-pl 8.05, chymotrypsin-pl 8.80, and
cytochrome c-pl 9.60.
Size Exclusion HPLC
A molecular sieving column (TSK G3000, Phenomenex,
Rancho Palos Verdes, CA) was equilibrated with PBS
containing 1% (w/v) octylglucoside , samples were applied,
and 1 ml aliquots collected, at a flow rate of 1
ml/minute. Absorbance was monitored at 280 nm
.
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Liaulus polyphemis Agglutinin (LPA) Chronatography
About 2 ml (final column volume) of LPA (E-Y
Laboratories, San Mateo, CA) were equilibrated with at
least 10 column volumes of 10 mM Tris buffer, pH 8.0,
containing 10 mM calcium chloride and 1% (w/v)
octylglucoside . Bovine cerebral cortex solubilized
proteins at various stages of purification were added to
the matrix and rotated on a Fisher Hematology/Chemistry
Mixer (Fisher Scientific, Pittsburgh, PA) continuously,
at 4°C, overnight. The LPA was washed until no
absorbance at 280 nm was detectable. Subsequently,
lectin-bound molecules were eluted with 100 mM sialic
acid, pH 8.0 with 0.1% EDTA and 1% (w/v) octylglucoside.
Eluted fractions were dialyzed against dilute PBS
containing 1% (w/v) octylglucoside and dried in a Speed
Vac Concentrator (Savant Instruments, Inc., Hicksville,
NY) .
Reduction and Blocking
Bovine cerebral cortex protein extracts were reduced
by adding ft-mercaptoethanol to a final concentration of
9% (v/v) and incubating at room temperature for 2 hours.
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The sulfhydryl groups were alkylated by dialysis against
100 mM iodoacetamide for 4 hours followed by dilute
(0.1 mM) iodoacetamide at 4°C, overnight.
Cell Culture
Swiss 3T3 cells were maintained as monolayer
cultures in humidified, 37°C incubators containing 95%
air and 5% carbon dioxide, as described by Kinders et
al., (1979). Cells were grown in Dulbecco's Modified
Eagle Medium (GIBCO Laboratories life Technologies, Inc.,
Grand Island, NY), supplemented with 10% calf serum
(Hazelton Dutchland, Inc., Denver, PA) and were harvested
for assay by scraping culture flasks with sterile rubber
policemen
.
Biological Inhibitory Activity
The method utilized to determine the capability of a
molecule to inhibit protein synthesis of cells has been
described by Kinders et al., (1979). Basically, Swiss
3T3 cells were harvested from subconfluent monolayers
after washing briefly with methionine-free Minimal
Essential Medium containing 25 mM HEPES buffer (MEM-
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HEPES). The cell suspension was then centrifuged; the
pelleted cells were resuspended and counted in a
hemacytometer, and diluted to provide 2-5 x 10 5 cells in
100 ul of warm (37°C), methionine-f ree MEM-HEPES
.
Potential inhibitory substances were pipetted into 13 X
100 mm test tubes at different concentrations, each in a
final volume of 40 ul in PBS. Cell aliquots were then
added and the tubes were incubated, at 37°C, for 30
minutes. At the end of this incubation, 2.0 uCi of a^S-
methionine in 10 ul of methionine-f ree MEM were added and
the tubes immediately reincubated, at 37°C, for 10
minutes. Incorporation was stopped by the addition of 2
ml ice-cold HKM buffer (10 mM HEPES, 120 mM potassium
chloride, and 5 mM magnesium chloride, pH 7.1) and
centrifugation of the cells, at 2,000 rpm, for 3 minutes.
After removal of supernatant liquid, the cells were lysed
with distilled, deionized water and 1 N sodium hydroxide,
followed by precipitation of proteins with an equal
volume of ice-cold 20% trichloroacetic acid.
Precipitated molecules were collected by centrifugation
and the previous steps repeated. On the third
repetition, trichloroacetic acid was omitted and a 100 ul
aliquot was removed for liquid scintillation counting.
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Innunob lotting
Samples were either directly spotted onto pre-wet
nitrocellulose (Schleicher and Schuell', Inc., Keene, NH
)
using a Minifold (Schleicher and Schuell, Inc., Keene,
NH ) or electrophoresed and electroblotted using a
Transphor Electrophoresis Cell (Hoefer Scientific
Instruments, San Francisco, CA) by the method of Towbin,
et al., (1979). Following transfer, the nitrocellulose
membrane was dried and then blocked overnight, at room
temperature, in blocking buffer (0.1 mM EDTA, 0.01% w/v
sodium iodide, 5 mM sodium chloride, 1 mM Tris, pH 7.0
and 0.3% Tween 20). The membrane was subsequently washed
5 times, for 5 minutes each, with wash buffer (1% w/v
sodium chloride, 100 mM Tris, pH 7.5 and 0.3% Tween 20).
Antibody was added, in blocking buffer, and the membranes
were incubated overnight, at room temperature. The blot
was washed again, followed by the addition of i25i_
radiolabeled staphylococcal Protein A at 100,000 CPM per
ml of blocking buffer. Finally, the membrane was washed,
dried and used to expose an X-ray film ( Agfa-Gevaert
,
Belgium)
.
41
RESULTS
Isolation
The strategy designed to purify the parental
sialoglycoprotein inhibitor is illustrated in Figure 1.
Fifteen independent isolates from fresh bovine cerebral
cortex tissue cell suspensions were studied. The cells
were pelleted by low speed centr ifugation and extracted
with 1% (w/v) octylglucoside. Only 4.0% of the total
cellular protein was extracted by this method. Following
solubilization, the cells were again centrifuged; the
supernatant fluid, containing detergent-extracted
proteins, was retained and concentrated by ultrafiltra-
tion. The concentrated extract contained 3.0% of the
total cerebral cortex cell protein, as measured by BCA
protein assay (Table 1).
Polyclonal Antibody Affinity Purification
The detergent-extracted proteins were applied to a
polyclonal antibody affinity column and subsequently
eluted with either ethanolamine or glycine, containing 1%
(w/v) octylglucoside (Fig. 2). In either case, the
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collected fractions were immediately neutralized,
dialyzed against dilute PBS, and analyzed by
electrophoresis. In parallel experiments with the 18,000
Dalton SGP inhibitor, it was determined that the
sialoglycopeptide was not efficiently released from a
polyclonal antibody affinity column by 50 mM ethanol-
amine
. Subsequently, biologically active SGP was
successfully eluted from the antibody column with less
than ten column volumes of 2M glycine, pH 2.5.
Because of the previous observation, the majority of
"parent" isolations were conducted using glycine as
elution buffer. The amount of protein recovered by
elution with 50 mM ethanolamine was 0.002% of the total
cerebral cortex cell protein compared to 0.003% of the
total cerebral cortex cell protein eluted with 2 M
glycine, pH 2.5 (Table 1).
Molecular Analysis of Polyclonal Antibody-Eluted Material
Proteins bound to the polyclonal antibody affinity
column were subjected to SDS-polyacrylamide gel
electrophoresis. Non-reduced preparations failed to
enter the separating gel, whereas, reduced preparations
demonstrated the presence of four distinct protein bands
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of apparent molecular weights of 175 kD , 135 kD , 66 kD
,
and 56 kD (Fig. 3). This indicated that the protein (or
proteins) might be a large complex that included four
subunits connected by disulfide bonds.
Although the non-reduced proteins failed to enter
polyacrylamide gels, it was possible that these high
molecular weight species might be discernable by size-
exclusion HPLC (high performance liquid chromatography).
Molecular sieving HPLC could have provided a convenient
means of separation of the antibody eluted molecules, but
the chromatographs from several preparations were
inconsistent (Fig. 4). The hydrophobicity of these
membrane proteins may have caused them to aggregate
randomly into various conformations in different
isolates. These complexes of diverse molecular size
could have produced different elution times and peak
areas in size-exclusion HPLC. In any event, it was
impossible to assess the molecular weight species by
HPLC.
Interestingly, the four reduced bands present in SDS
gels were no longer obvious upon isoelectric focusing.
Isoelectric focusing of the polyclonal antibody affinity
purified material, revealed only a slight difference
between non-reduced and reduced samples. Focusing did
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not produce distinct protein bands, but did show that the
molecules present were acidic and heterogeneous with
regard to their isoelectric points (Fig. 5). This
heterogeneity suggested that the proteins were
glycosylated and/or sialylated to varying degrees.
In order to determine if the antibody-bound
molecule(s) contained N-acetylneuraminic acid (NANA),
binding to a NANA-specif ic lectin, Limulus polyphemus
agglutinin (LPA), was examined. It appeared that at
least a portion of the isolated material contained
sialic acid because, on average, forty percent of the
protein applied to the LPA column bound, and in an early
experiment neuraminidase-treated proteins were shown not
to bind to the LPA. However, the amount of glycoprotein,
in separate preparations, eluted from LPA by competition
with sialic acid varied from three to seventy-six percent
bound of the total protein applied. Polyacrylamide gels
revealed similar staining patterns in both the LPA-bound
and LPA-unbound fractions.
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Reduction and Blocking of Polyclonal Antibody-Eluted
Material
Due to the problem of aggregation of the molecules
when under non-reducing conditions, it was thought that
reduction followed by alkylation to prevent reformation
of disulfide bonds might aid in the elucidation of the
specific subunit directly related to the sialoglyco-
peptide inhibitor. By decreasing the probability for
subunits to bind together in disulfide linkages, it
seemed possible that the molecules might remain separate
during analysis or that, perhaps, the subunit most
similar to the SGP might be less hydrophobic than the
other subunits.
Reduction was accomplished using a final concen-
tration of 9% (v/v) ft-mercaptoethanol and subsequent
alkylation was performed with 100 mM iodoacetamide
.
Sufficient blocking was demonstrated to have occurred by
subjecting the alkylated molecules to SDS-PAGE in the
absence of reducing agents (Fig. 6). The proteins
stained by Coomassie Blue were analogous to those seen
previously under reduced conditions (Fig. 3).
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Reduction and alkylation did not appear to
facilitate separation and identification of the subunit
directly related to the SGP . For example, a reduced and
blocked preparation was applied to an LPA column,
producing results which were similar to those seen with
non-reduced, non-alkylated protein. Approximately fifty
percent of the sample applied to the LPA column was bound
and released. Which of the four bands seen in SDS-PAGE
actually had NANA residues was not well-defined by
electrophoretic analysis of the LPA-bound and unbound
fractions. Based on SDS gels, all of the proposed
subunits recovered from the lectin column contained
sialic acid. Nearly identical staining patterns were
observed in both bound and unbound samples.
Biological Activity of Polyclonal Antibody-Eluted
Material
Although the molecular characterization was
ambiguous, auspicious results were obtained from a
biological activity assay. One of the initial criteria
demanded that the "parent" to the sialoglycopeptide cell
growth inhibitor should be capable of inhibiting cell
47
growth and/or protein metabolism. Polyclonal antibody-
purified material was dialyzed to remove detergent and
tested for its ability to inhibit Swiss 3T3 cells from
incorporating radiolabeled methionine.
In one such experiment, protein synthesis was
effectively inhibited by the putative "parent" molecule.
A dose-responsive inhibition of protein synthesis was
observed in Swiss 3T3 cells treated with various
concentrations of antibody-purified proteins (Fig. 7).
Additional trials of the biological activity assay did
not reproduce the inhibition described here; therefore,
the conclusion that the isolated protein was the "parent'
of the SGP inhibitor was not experimentally confirmed.
The amount of potential "parent" protein used in
biological activity assays was based on experiments
performed with the inhibitory peptide. In preliminary
isolations of the "parent", the protein was demonstrated
to have an apparent molecular weight of 180,000 Daltons,
which was ten times as large as the peptide inhibitor.
At the time this assay was performed, 2 ug of SGP
(peptide) was equivalent to one unit of biological
activity, which was defined as that amount of protein
that inhibited methionine incorporation by 25%.
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Consequently, 20 ug of the suspected "parent" protein was
the minimum used in cell protein synthesis experiments.
After heating the antibody-isolated fraction to
100°C for 30 minutes, no inhibition of methionine
incorporation was evident in Swiss 3T3 cells, suggesting
that the inhibition described above resulted from the
presence of a non-denatured protein.
The inhibition was not due to the presence of
detergent in the protein samples, because the dialysate
from the octy lglucoside removal step was used as a
control. Additionally, dilutions of detergent were
assayed in a separate experiment which demonstrated that
up to 0.02% octylglucoside would not significantly
inhibit protein synthesis in Swiss 3T3 cells (Table 2).
Inmunoblotting of Polyclonal Antibody-Eluted Material
Since at least one experiment indicated that a
protein in the polyclonal antibody purified fraction was
inhibitory, it seemed logical that the molecule
responsible for inhibition could be identified by
immunoblot analysis. Polyclonal antibody-isolated
material, LPA-eluted material, and crude octylglucoside
solubilized material were subjected to immunoblot
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analysis. Blots were performed by direct application of
samples to nitrocellulose (dot blots) and by SDS-PAGE
followed by electrophoret ic transfer to nitrocellulose
(Western blots). Efficient transfer of proteins was
demonstrated by negative gel staining with Coomassie Blue
and positive membrane staining with Ponceau S. The
18,000 Dalton SGP inhibitor, which had been used as the
immunogen, successfully bound polyclonal antibody in an
immunoblot. During the course of this study, no reactive
species from either affinity purified samples or crude
octylglucoside extracted samples were detected in
immunoblots. However, more recently generated antiserum
does react with detergent solubilized and. immunoaf f inity
column purified proteins in a dot blot.
Non-specific Binding to the Polyclonal Antibody Column
Based on the lack of evidence that the isolated
proteins consistently reacted with polyclonal antibody,
it was suspected that the immunoaf f inity column may not
have been binding specifically to SGP-related molecules.
Non-specific binding was tested experimentally by
applying solubilized material to an uncoupled, blocked
agarose column. In this manner, it was shown that
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detergent-extracted proteins actually bound to the
uncoupled agarose to nearly the same extent that they
bound to antibody-coupled agarose (Table 3). This
suggested that the concentration of antibody ligated to
the matrix was too low or that the isolated proteins had
some affinity for the matrix itself.
In order to reduce such non-specific binding, a new
immunoaf f inity column was prepared using a 10-100 fold
greater concentration of antibody and an uncoupled
agarose column was inserted into the isolation strategy
as a pre-column. Neither of these procedures appeared to
facilitate the purification of an immunoreactive protein,
as measured by blotting.
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DISCUSSION
The ultimate goal of this project was to purify the
native form, or "parent" of the bovine cerebral cortex
cell surface sialoglycopeptide growth inhibitor. During
the process of attempting to purify the membrane
sialoglycoprotein, valuable information was discovered.
The purification of the native membrane sialo-
glycoprotein cell growth inhibitor proved to be a more
formidable exercise than originally perceived.
Purification was difficult for several reasons. First,
the "parent" sialoglycoprotein probably constituted a
mere fraction of the total cellular proteins, because its
derivative was a minor bovine brain protein. Only
microgram quantities of the SGP cell growth inhibitor
were separated from over 100 grams of cerebral cortex
tissue (Sharifi et si., 1986).
The isolation of some protein which was relatively
abundant would have been a less arduous task. For
example, the isolation of comparatively large quantities
of hemoglobin would have been facilitated by its known
high concentration in blood: 14-16 grams of hemoglobin
per 100 ml of whole blood (from New England Journal of
Medicine, 1980).
52
While hemoglobin is relatively abundant in blood,
growth factors are present in much lower concentrations
in serum and growth factor receptors are comparatively
scarce on cell surfaces. One group of researchers was
fortunate that a unique cell line was discovered. The
recognition that an epidermoid carcinoma cell line, A431,
specifically bound approximately ten-fold more EGF than
other human cell lines (Fabricant, DeLarco, and Todaro,
1977) enhanced the purification of the EGF receptor
(Cohen, Carpenter, and King, 1980). In the present
study, an abnormally rich source of the desired molecule
might have been utilized, if such a source were available
or identifiable.
As in the isolation of the SGP , it was speculated
that brain tissue, because of its growth-arrested state
in vivo, was a propitious source of potential cell growth
inhibitory elements. It was known, as stated above, that
the 18,000 Dalton SGP inhibitor was present on the
surface of bovine cerebral cortex tissue in limited
quantities, but it was uncertain whether or not the
number of parental molecules would correlate with the
number of SGP molecules.
Isolating a minute portion of the total cellular
protein was difficult enough, but the fact that the
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extracted membrane proteins were hydrophobic and
predisposed to aggregation added another dimension to the
dilemma. Further increasing the magnitude of the
purification problem was the finding that at least some
of the solubilized proteins tended to bind non-
specifically to the immunoaf f inity column.
Some of these difficulties must have been
encountered by others in the pursuit of membrane
inhibitory molecules. Several researchers have claimed
to purify such negative growth regulators, but have not
demonstrated conclusively that their preparations were
indeed pure.
The "purification" of a growth inhibitor from
Ehrlich ascites mammary carcinoma cells by Boehmer et
al., (1984) demonstrated the presence of an inhibitory
protein of approximate molecular weight between 12,000
and 14,000 Daltons. The molecular weight of the major
protein isolated by Grosse's group was later described as
13,000 Daltons (Boehmer et al., 1985), but the 12&I-
labeled inhibitory fraction appears as a single protein
band only after fixing and washing gels as if preparing
for silver staining. When gels were not prepared for
silver staining, multiple bands were present. Biological
activity was tested in samples which were n.Q.t treated for
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silver staining, therefore, inhibitory properties cannot
be unconditonally attributed to the 13,000 Dalton
protein. Because it was not clear that the major protein
discussed above was responsible for cellular inhibition
and, in an earlier publication (Boehmer et al., 1984),
the greatest proportion of inhibitory activity was
attributed to a fraction which displayed an almost
invisible protein band, the possibility exists that a
minor protein actually affected cell growth.
Another group that happened upon difficulties in
working with inhibitory molecules was Luis Glaser's lab.
Glaser and coworkers isolated 3T3 cell membranes which
were shown to inhibit cell growth ( Whittenberger and
Glaser, 1977). The published work was criticized because
Glaser et al. had not purified the specific inhibitory
element from the cell membrane. The arguments against
Glaser included the fact that the membrane fragments
could, in essence, be "smothering" the cells by not
allowing interaction of growth factors in the medium with
receptors on the cell surface. To refute the contention
that cells treated with membrane fragments were inhibited
due to lack of stimulation by resident growth factors,
Whittenberger and Glaser (1978) submitted an elegant
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experiment which displayed that limited diffusion was not
responsible for interruption of cell growth in culture.
Whittenberger et al . , (1978) subsequently
solubilized the membrane fragments and demonstrated that
the extracted proteins could also inhibit cell
metabolism. Three years later, the growth inhibitory
proteins remained "partially purified" (Raben, Lieberman,
and Glaser, 1981), suggesting that the researchers had
not been successful at separating a homogeneous protein.
One of the biggest obstacles in the present study
was the tendency of the extracted molecules to aggregate.
There is a precedent for such difficulties: Patt and
Houck (1980) reported that "chalones", endogenous mitotic
inhibitors, had an "aggregative avidity ... for various
macromolecules.
"
The propensity for the isolated proteins to
aggregate may have been the cause of some of the
inconsistent experimental results. The inconsistencies
may have resulted from variations in the arrangement of
the aggregates. For instance, one of five biological
activity assays was successful in demonstrating
inhibition of cellular protein synthesis. This may have
been because, in that particular trial, the protein
complex was arranged such that the inhibitory portion of
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the "parent" molecule was available for binding to the
surface of 3T3 cells, thereby signaling the cells to
cease proliferation.
Aside from its relatively low abundance on cerebral
cortex cells and the aggregative behavior of the native
sialoglycoprotein, a substantial inconvenience was the
preparation and utilization of an immunoaf f inity column.
This project was based on the supposition that a "parent"
molecule actually existed on the surface of bovine
cerebral cortex cells. Furthermore, it was speculated
that the membrane glycoprotein in its native conformation
contained an epitope which would bind to and was
available to polyclonal antibodies raised against the SGP
inhibitor
.
Consequently, the preparation of an immunoaf f inity
column using the previously isolated polyclonal
antibodies was presumed to be of vital significance.
While utilizing the antibody affinity column, non-
specific binding of the solubilized proteins to the
column became apparent. The interpretation of this
result was that either the extracted molecules had a high
affinity for the column (matrix, etc.) or the antibodies
had a low (or no) affinity for the "parent" glycoprotein.
The antibody may not have bound the "parent" molecule
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because the membrane glycoprotein complex conformation
was such that the epitope(s) was (were) hidden. More
than likely, a combination of the former was responsible
for these results.
The polyclonal antibody used in the present study
had been passed through an affinity column coupled with
purified SGP (Sharif i, unpublished). The affinity-
purified antibody was shown to have high affinity for the
peptide inhibitor in radioimmunoassays (Fleenor,
unpublished), but assays with tissue culture cells and
bovine cerebral cortex cells failed to display
immunofluorescence (Fleenor, unpublished). The inability
to demonstrate fluorescence was attributed to a cell
surface concentration of SGP that was under the limits of
detection of the assay. Alternatively, the epitope(s)
might have been masked by other cell surface proteins or
the native protein itself.
A potential solution to the dilemma of non-specific
binding to the immunoaf f inity column would be to increase
the quantity of antibody coupled to the column matrix,
provided that the non-specific binding described here was
due to proteins binding to the matrix and/or the plastic
column. The evidence presented by the binding of
molecules to the uncoupled agarose strongly suggests that
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this could be the case. It is plausible that the
purification of the parental sialoglycoprotein could be
enhanced by the availability of a greater supply of
antibody and/or by a higher affinity antibody.
The affinity columns prepared in this study were not
coupled to maximum capacity, which may have provided
extra matrix surface area to which the proteins might
adhere. Logically, if the agarose beads were coupled to
capacity, then there would be fewer potential binding
sites on the matrix itself. Other laboratories have
encountered difficulties in protein purification on
activated agarose columns which were coupled at low
densities (J. Hughes, personal communication).
Additionally, antibody with a greater affinity or
alternative binding site might alleviate some of the
problems mentioned. The study described here may have
resulted in the isolation of the native membrane
sialoglycoprotein, but because of the difficulties
encountered, the "parent" molecule has not been
conclusively identified. Newly generated antibody could
conceivably react positively in an immunoblot and,
thereby, remove some of the ambiguity and doubt described
above. Such an antibody appears to have been produced
recently. This novel antiserum has not only bound crude
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bovine cerebral cortex protein, detergent-extracted
protein, and several of the original brain isolates in a
dot blot, but also bound potential "parent" molecule to a
freshly prepared immunoaf f inity column. Thereafter, an
immunoreactive species was identified in the eluate from
the new column. These preliminary results indicate that
an antigenic determinant is actually present and
accessible in the octylglucoside solubilized material.
Hopefully, this antibody will assist in the search for
the native membrane sialoglycoprotein , provided the other
obstacles described here are also conquered.
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TABLE 1. Purification of the parental sialoglycoprotein
Purification Step
Cerebral Cortex Cells
Octylglucoside Extract
Concentrated Extract
Polyclonal Antibody Bound
(released with glycine)
Protein Total
(mg/g wet tissue) (%)
125.0
5.5
3.9
0.004
100
3
0.003
Protein concentrations were determined by the BCA
protein assay as described in Materials and Methods.
Data shown are from a typical bovine cerebral cortex
preparation
.
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TABLE 2. Inhibition of nethionine incorporation by
octylglucoside
.
Octylglucoside Concentration Inhibition
(% w/v) <% of control)
(control)
0.012
0.025 6
0.05 12
0.1 40
0.25 99
0.5 99
1.0 99
Aliquots of 100 ul methionine-free MEM-HEPES
containing 2-5 x 10 5 Swiss 3T3 cells were incubated with
40 ul samples of various concentrations of octylglucoside
in PBS for 30 minutes, at 37°C. At the end of this
incubation, the cells were radiolabeled with 2.0 uCi of
35 S-methionine , at 37°C, for 10 minutes and processed as
described in Materials and Methods. These data represent
the averages of duplicate samples.
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TABLE 3. Non-specific binding of proteins to uncoupled
agarose
.
Column Type Protein Bound Total
(ng) <*>
Polyclonal Antibody Coupled,
Blocked Affi-gel 10 20 1.9
Uncoupled, Blocked Affi-gel 10 18 1.7
Agarose 31 2.9
Aliquots of 1 mg of solubilized bovine cerebral
cortex proteins were applied to the columns, incubated at
4°C, overnight, and subsequently eluted with 2 M glycine,
pH 2.5. Protein concentrations were determined by BCA
protein assay. These data represent the averages of
three experiments.
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Figure 1. General purification procedure for the
isolation of the bovine cerebral cortex cell
membrane sialoglycoprotein
.
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Bovine Cerebral Cortex Cells
(suspended in DMEM-HEPES)
Centrifuge at 1500 rpm
Pellet
1
Supernatant fluid
(discard)
Solubilization with
1% Octyl-beta-D-glucopyranoside
Centrifuge at 1500 rpm
Supernatant fluid
1
Pellet
(discard)
Concentration by ultrafiltration
r
Polyclonal antibody
affinity column
PAGE
Unbound
Bound
Figure 2. Polyclonal antibody affinity column elution of
the potential "parent" sialoglycoprotein . The
octylglucoside extracted fraction containing
approximately 5 mg protein was loaded onto
Affi-gel 10 previously coupled with polyclonal
antibody. The single eluted peak was
collected and analyzed.
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Figure 3. SDS-PAGE of fractions purified by
immunoaffinity chromatography. Three separate
preparations were electrophoresed in a gel
with a linear gradient of 5-20%
polyacrylamide. The preparations were
analyzed under non-reducing (Lanes 1-3) and
reducing (Lanes 5-7) conditions. Each lane
was loaded with 5 ug protein. Lanes 1 and 5
contain samples from the same brain
preparation, as do Lanes 2 and 6, and Lanes 3
and 7. Lane 4 contains molecular weight
standards
.
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Figure 4. Size-exclusion HPLC analysis of immunoaf
f
inity
eluted fraction. Samples containing 10 ug of
protein were loaded on a TSK G3000 HPLC column
previously equilibrated with phosphate-
buffered saline, pH 7.2. The attenuation was
set at 16 and the flowrate was 1 ml per
minute. Panels A-D illustrate HPLC profiles
from four separate brain isolates. Elution
times are as indicated.
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Figure 5. Isoelectric focusing of immunoaf f inity eluted
fraction. The purified protein was radio-
iodinated and isoelectric focused for 1.5
hours at 25 Watts. Samples of 100,000 CPM
were loaded into each lane. Sample A was
reduced while Sample B was not reduced.
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Figure 6. SDS-PAGE of reduced and alkylated
immunoaff inity eluted fraction. A sample of
5 ug of blocked protein was electrophoresed in
a gel with a linear gradient of 5-20%
polyacrylamide in the absence of reducing
agents. Lane 1 is the blocked sample and Lane
2 contains molecular weight standards.
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Figure 7. Inhibition of 3T3 cell protein synthesis by an
immunoaf f inity eluted fraction. Cells in
100 ul of DMEM-HEPES were incubated at 37°C in
the presence of 20 ul of the isolated protein
in PBS, as described in Materials and Methods.
Assay was performed in duplicate and results
are expressed as percentage of inhibition as
compared with control cultures, which received
only PBS. The vertical bars depict the range
of duplicate samples and the * indicates a
sample which was heated to 100°C for 30
minutes prior to addition to cells.
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ABSTRACT
Density-dependent control of cell growth in culture
may result from specific inhibitory molecules in cell
membranes interacting with specific receptors in
neighboring cell membranes. A molecule with such
potential has been proteolytically cleaved from the
surface of bovine cerebral cortex cells and has been
shown to inhibit cell division, protein synthesis, DNA,
and RNA synthesis of several cultured cell lines. The
present study utilized polyclonal antibody against the
sialoglycopeptide inhibitor in an attempt to isolate the
intact, native membrane protein from which the inhibitor
was originally derived. Bovine cerebral cortex cells
were solubilized with octy l-J3-D-glucopyranoside
(octylglucoside) and the solubilized molecules subjected
to immunoaf f inity chromatography. The polyclonal
antibody bound fraction was examined by SDS-PAGE, IEF,
HPLC, lectin affinity chromatography and immunoblot
analysis. The isolated material was also tested for
biological activity in a protein synthesis inhibition
assay. Upon reduction in an SDS polyacrylamide gel, the
antibody-bound fraction displayed four distinct molecular
weight bands. The extracted protein inhibited protein
synthesis in Swiss 3T3 cells; however, this inhibition
was not predictably repeatable. Immunoblots failed to
reveal antibody binding activity in either the affinity
purified material or in crude detergent solubilized
fractions. Based on the evidence presented, it cannot be
concluded that the fraction isolated was indeed the
native membrane sialoglycoprotein . However, at the time
of this writing, preliminary results indicate that
octylglucoside extracted molecules react with more
recently generated antiserum.
